Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
hVIVO plc (Ticker: HVO) is full-service early phase Contract Research Organisation (CRO) and the global leader in human challenge trials. The company delivers end-to-end clinical development services to a diverse and expanding client base, including seven of the world's ten largest biopharma companies. hVIVO specialises in conducting human challenge trials across multiple infectious and...
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued o
Target Price
The average target price of HVO.L is 18 and suggests 93% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
Buy
Sell